Advanced diabetes care: Three levels of prediction, prevention & personalized treatment

Current Diabetes Reviews

Volumn 6, Issue 1, 2010, Pages 42-51

  Golubnitschaja, Olga ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Cardiovascular Cancer Neurodegenrative complications; Diabetes mellitus; Educators; Healthcare; Healthcare providers; Morbidity mortality; Personalized medicine; Policymakers; Predictive diagnosis; Preventive measures; Socio economical burden

Indexed keywords

BIOLOGICAL MARKER; HORMONE; MITOCHONDRIAL DNA; PANCREAS POLYPEPTIDE; PROTEINASE INHIBITOR; SCLEROPROTEIN; SECRETORY PROTEIN;

BLADDER; CARDIOVASCULAR DISEASE; CELL ADHESION; CELL DAMAGE; CELL FUNCTION; CELL POPULATION; CHROMOSOME; COLON; DEGENERATIVE DISEASE; DEMENTIA; DETOXIFICATION; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC FOOT; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE PREDISPOSITION; DNA REPAIR; ENDOMETRIUM; ENVIRONMENTAL FACTOR; ENZYME RELEASE; GENE INTERACTION; GENE THERAPY; HELICOBACTER PYLORI; HIGH RISK POPULATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; IN VITRO STUDY; INCIDENCE; INSULIN RELEASE; INTERPERSONAL COMMUNICATION; KIDNEY; KIDNEY INJURY; LIFE EXPECTANCY; LIFESPAN; LIFESTYLE MODIFICATION; LIVER; MITOCHONDRIAL GENE; MITOCHONDRION; MORBIDITY; MORTALITY; NEOPLASM; NEWBORN HYPOXIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; OVARY; PANCREAS; PANCREAS ISLET BETA CELL; PATIENT CARE; PERINATAL ASPHYXIA; PREDICTION; PREMATURE AGING; PREVALENCE; PREVENTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEOMICS; QUALITY OF LIFE; RECTUM; REVIEW; RISK; RISK FACTOR; SILENT MYOCARDIAL ISCHEMIA; STOMACH; TISSUE REGENERATION;

CLINICAL TRIALS AS TOPIC; DIABETES COMPLICATIONS; DIABETES MELLITUS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPOGLYCEMIC AGENTS; PATIENT EDUCATION AS TOPIC; PREVALENCE; WORLD HEALTH;

EID: 77950792786     PISSN: 15733998     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339910790442637     Document Type: Review

References (49)

1. Tripathi B, Srivastava AK. Diabetes mellitus: complications and therapeutics. Med Sci Monit 2006; 12: 130-147
2. Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res 2007; 125: 217-230 (Pubitemid 46805444)
3. Kowluru RA, Chan PS. Oxidative stress and diabetic retinopathy. Exp Diabetes Res 2007; 2007: 43603.
4. Hauner H. Epidemiology and costs of diabetes mellitus in Germany. Dtsch Med Wochenschr 2005; 130: 64-65
5. Chaturvedi N. The burden of diabetes and its complications: trends and implications for intervention. Diabetes Res Clin Pract 2007; 76: S3-12.
6. American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care 2008; 31: 596-615.
7. Borch-Johnsen K, Beck-Nielsen H, Christiansen JS, et al. Guidelines on diagnosis of type 2 diabetes. Investigation, diagnosis and glucose measurement. Ugeskr Laeg 2003; 165: 1558-1561
8. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-1431
9. Hogan P, Dall T, Nikolov P, American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care 2003; 26: 917-932
10. Glaser NS. Non-insulin-dependent diabetes mellitus in childhood and adolescence. Pediatr Clin North Am 1997; 44: 307-337
11. Pinhas-Hamiel O, Dolan LM, Daniels SR, Standiford D, Khoury PR, Zeitler P. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr 1996; 128: 608-615
12. Huang TT, Goran MI. Prevention of type 2 diabetes in young people: a theoretical perspective. Pediatr Diabetes 2003; 4: 38-56.
13. Rosenbloom AL, Joe JR, Young RS, Winter WE. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999; 22: 345-354
14. Golubnitschaja O. In: Golubnitschaja O, Ed, Predictive diagnostics and personalized treatment: Dream or Reality? New York: Nova Science Publishers 2009; pp. 147-150
15. Cebioglu M, Golubnitschaja O. In: Golubnitschaja O, Ed, Predictive diagnostics and personalized treatment: Dream or Reality? New York: Nova Science Publishers 2009; pp. 151-156
16. Cebioglu M, Schild HH, Golubnitschaja O. In: Golubnitschaja O, Ed, Predictive diagnostics and personalized treatment: Dream or Reality? New York: Nova Science Publishers 2009; pp. 247-262
17. Yeghiazaryan K, Skowasch D, Bauriedel G, Schild HH, Golubnitschaja O. In: Golubnitschaja O, Ed, Predictive diagnostics and personalized treatment: Dream or Reality? New York: Nova Science Publishers 2009; pp. 73-101.
18. Zaini A. Where is Malaysia in the midst of the Asian epidemic of diabetes mellitus? Diabetes Res Clin Pract 2000; 2: 23-28
19. Golubnitschaja O. Clinical Proteomics in application to predictive diagnostics and personalized treatment of diabetic patients. Current Proteomics 2008; 5: 35-44.
20. Costigliola V, Gahan P, Golubnitschaja O. In: Golubnitschaja O, Ed, Predictive diagnostics and personalized treatment: Dream or Reality? New York: Nova Science Publishers 2009; pp. 1-3.
21. Peeva V, Golubnitschaja O. In: Golubnitschaja O, Ed, Predictive diagnostics and personalized treatment: Dream or Reality? New York: Nova Science Publishers 2009; pp. 499-507.
22. Yeghiazaryan K, Peeva V, Morelli M, Herrera-Marschitz M, Golubnitschaja O. In: Golubnitschaja O, Ed, Predictive diagnostics and personalized treatment: Dream or Reality? New York: Nova Science Publishers 2009; pp. 509-525
23. Nakano T, Ito H. Epidemiology of diabetes mellitus in old age in Japan. Diabetes Res Clin Pract 2007; 1: 76-81.
24. du Prel JB, Icks A, Grabert M, Holl RW, Giani G, Rosenbauer J. Socioeconomic conditions and type 1 diabetes in childhood in North Rhine-Westphalia, Germany. Diabetologia 2007; 50: 720-728
25. Placzkiewicz-Jankowska E, Szybinski Z, Huszno B. Environmental factors in the development of type 1 diabetes - a new insight. Prz Lek 2007; 64: 175-179
26. Lesgards JF, Durand P, Lassarre M, et al. Assessment of lifestyle effects on the overall antioxidant capacity of healthy subjects. Environ Health Perspect 2002; 110: 479-486
27. Niwa Y, Ishimoto K, Kanoh T. Induction of superoxide dismutase in leukocytes by paraquat: correlation with age and possible predictor of longevity. Blood 1990; 76: 835-841
28. Koehn J, Turhani D, Krapfenbauer K. In: Golubnitschaja O, Ed, Predictive diagnostics and personalized treatment: Dream or Reality? New York: Nova Science Publishers 2009; pp. 183-212.
29. Cebioglu M, Schild HH, Golubnitschaja O. Diabetes mellitus as a risk factor for cancer: stress or viral etiology? Infect Disord Drug Targets 2008; 8: 76-87.
30. Frustaci A, Kajstura J, Chimenti C, et al. Myocardial cell death in human diabetes. Circ Res 2000; 87: 1123-1132
31. Mozaffari MS, Abdelsayed R, Schaffer SW. In: Golubnitschaja O, Ed, Predictive diagnostics and personalized treatment: Dream or Reality? New York: Nova Science Publishers 2009; pp. 157-182
32. Schaub S, Wilkins J, Weiler T, Sangster K, Rush D, Nickerson P. Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry. Kidney Int 2004; 65: 323-332
33. Mayr M, Mayr U, Chung YL, Yin X, Griffiths JR, Xu Q. Vascular proteomics: linking proteomic and metabolomic changes. Proteomics 2004; 4: 3751-3761
34. Gahan PB. Circulating nucleic acids in plasma and serum: roles in diagnosis and prognosis in diabetes and cancer. Infect Disord Drug Targets 2008; 8: 100-108
35. Gahan PB. In: Golubnitschaja O, Ed, Predictive diagnostics and personalized treatment: Dream or Reality? New York: Nova Science Publishers 2009; pp. 31-54.
36. Golubnitschaja O. Method for early diagnosis of proliferative diabetic retinopathy. 2006; International Patent No. 06115230.2.
37. Golubnitschaja O. In: Golubnitschaja O, Ed, Predictive diagnostics and personalized treatment: Dream or Reality? New York: Nova Science Publishers 2009; pp. 213-229
38. Josifova T, Schneider U, Henrich PB, Schrader W. Eye disorders in diabetes: potential drug targets. Infect Disord Drug Targets 2008; 8: 70-75
39. Josifova T, Henrich PB, Schrader W. In: Golubnitschaja O Ed, Predictive diagnostics and personalized treatment: Dream or Reality? New York, Nova Science Publishers. 2009, pp. 231-246.
40. Schoen FJ, Levy RJ. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann Thorac Surg 2005; 79: 1072-1080
41. Golubnitschaja O. Cell cycle checkpoints: the role and evaluation for early diagnosis of senescence, cardiovascular, cancer, and neurodegenerative diseases. Amino Acids 2007; 32: 359-371
42. Golubnitschaja O, Yeghiazaryan K, Skowasch D, Schild H, Bauriedel G. p21WAF1/CIP1 and 14-3-3 sigma gene expression in degenerated aortic valves: a link between cell cycle checkpoints and calcification. Amino Acids 2006; 31: 309-316
43. Yeghiazaryan K, Skowasch D, Bauriedel G, Schild H, Golubnitschaja O. Could activated tissue remodeling be considered as early marker for progressive valve degeneration? Comparative analysis of checkpoint and ECM remodeling gene expression in native degenerating aortic valves and after bioprosthetic replacement. Amino Acids 2007; 32: 109-114
44. Yeghiazaryan K, Bauriedel G, Schild HH, Golubnitschaja O. Prediction of degeneration of native and bioprosthetic aortic valves: issue-related particularities of diabetes mellitus. Infect Disord Drug Targets 2008; 8: 88-99.
45. Yeghiazaryan K, Skowasch D, Bauriedel G, Schild HH, Golubnitschaja O. In: Golubnitschaja O Ed, Predictive diagnostics and personalized treatment: Dream or Reality? New York, Nova Science Publishers. 2009.
46. Coelho JF, Ferreira P, Gil MH. New approaches in drug delivery systems: application for diabetes treatment. Infect Disord Drug Targets 2008; 8: 119-128
47. Coelho JFJ, Ferreira P, Fonseca AC, et al. In: Golubnitschaja O Ed, Predictive diagnostics and personalized treatment: Dream or Reality? New York, Nova Science Publishers. 2009, pp. 285-303.
48. Harrison PT. Application of gene therapy in diabetes care. Infect Disord Drug Targets 2008; 8: 129-133
49. Harrison PT, Flynn R, Lee CM. In: Golubnitschaja O Ed, Predictive diagnostics and personalized treatment: Dream or Reality? New York, Nova Science Publishers. 2009, pp. 103-127.